Point72 Hong Kong’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,400
Closed -$1.64M 354
2022
Q3
$1.64M Buy
23,400
+18,100
+342% +$1.42M 0.06% 407
2022
Q2
$425K Sell
5,300
-5,500
-51% -$430K 0.02% 767
2022
Q1
$819K Sell
10,800
-39,800
-79% -$3.15M 0.03% 573
2021
Q4
$4.32M Sell
50,600
-88,400
-64% -$6.9M 0.15% 134
2021
Q3
$10.5M Buy
139,000
+88,800
+177% +$7.05M 0.34% 28
2021
Q2
$4.08M Buy
50,200
+30,200
+151% +$2.47M 0.13% 175
2021
Q1
$1.58M Buy
20,000
+9,000
+82% +$705K 0.05% 492
2020
Q4
$941K Buy
+11,000
New +$910K 0.04% 499

Other funds holding CL

Point72 Hong Kong's CL Position: Q2 2024 in Review

Point72 Hong Kong sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 209,251 shares — an estimated $18.8M sold.

Point72 Hong Kong first reported a position in CL in Q1 2017 and held it in 14 quarters. The position peaked at $18.8M in Q1 2024. 1,820 funds tracked by Wall St. Rank hold CL as of Q2 2024.

  • Point72 Hong Kong reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
  • Point72 Hong Kong sold 209,251 Colgate-Palmolive shares in Q2 2024, an estimated $18.8M.
  • Point72 Hong Kong first reported a position in Colgate-Palmolive in Q1 2017 and held it in 14 quarters.
  • Point72 Hong Kong's Colgate-Palmolive position peaked at $18.8M in Q1 2024.
  • 1,820 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on Point72 Hong Kong's 13F filing for Q2 2024, filed 14 Aug 2024.